论文部分内容阅读
目的对冠心宁注射液在治疗冠心病心绞痛方面的临床疗效进行分析。方法选取2010年1月到2011年10月在本院治疗的冠心病心绞痛患者80名,随机分成观察组和对照组各40例,对比分析两组临床疗效。结果观察组优良率92.5%;对照组优良率70%。两组患者的临床疗效优良率具有显著性差异,P<0.05,有统计学意义。结论冠心宁注射液在治疗冠心病心绞痛方面具有显著的临床疗效,并安全性很好,值得临床广泛推广使用。
Objective To analyze the clinical efficacy of Guanxinning injection in the treatment of angina pectoris. Methods Eighty patients with coronary heart disease and angina pectoris treated in our hospital from January 2010 to October 2011 were randomly divided into observation group (40 cases) and control group (40 cases). The clinical curative effect was compared between the two groups. Results The excellent and good rate of the observation group was 92.5%; the excellent and good rate of the control group was 70%. Two groups of patients with excellent clinical efficacy rate was significantly different, P <0.05, with statistical significance. Conclusion Guanxinning injection in the treatment of angina pectoris has significant clinical efficacy and safety is good, it is widely used in clinical promotion.